Sabaa Pharmaceuticals
Sabaa Pharmaceuticals, also known as Sabaa Pharma, is a prominent player in the pharmaceutical industry, headquartered in Egypt. Founded in 2015, the company has rapidly established itself as a leader in the development and manufacturing of high-quality generic and innovative medicines, primarily serving the Middle East and North Africa regions. With a focus on therapeutic areas such as oncology, cardiology, and infectious diseases, Sabaa Pharmaceuticals is dedicated to improving patient outcomes through its unique product offerings. The company prides itself on its state-of-the-art facilities and adherence to international quality standards, which have positioned it as a trusted name in the market. Notable achievements include a robust portfolio of products that cater to diverse healthcare needs, reflecting its commitment to excellence and innovation in the pharmaceutical sector.
DitchCarbon Score
How does Sabaa Pharmaceuticals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sabaa Pharmaceuticals's score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sabaa Pharmaceuticals's reported carbon emissions
Sabaa Pharmaceuticals, headquartered in Egypt (EG), currently does not have available carbon emissions data for recent years. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. Additionally, there are no documented reduction targets or climate pledges from the company at this time. This absence of data suggests that Sabaa Pharmaceuticals may still be in the early stages of developing a comprehensive climate strategy or reporting framework. In the context of the pharmaceutical industry, companies are increasingly recognising the importance of addressing climate change and setting measurable targets to reduce their carbon footprint. As the sector moves towards greater sustainability, it will be essential for Sabaa Pharmaceuticals to establish clear commitments and initiatives to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sabaa Pharmaceuticals is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
